IPO Boutique

Angion Biomedica Corp. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Angion Biomedica Corp., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Angion Biomedica Corp.ANGN -
NASDAQ
$14.00-$16.00 $16.00 $17.625 million2/5/2021
Cowen, Stifel
Co-Manager(s):
HC Wainwright, Oppenheimer
Health Care
Filing(s):

1st Filed 2014-04-15
Terms Added 2014-05-24
Filed 2021-01-15
Terms Added 2021-02-01



Angion Biomedica Corp. Quote & Chart - Click for current quote - ANGN

About Angion Biomedica Corp. (adapted from Angion Biomedica Corp. prospectus):
They are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.

This description is adapted from Angion Biomedica Corp. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Angion Biomedica Corp. "ANGN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved